1. Home
  2. GASS vs BDSX Comparison

GASS vs BDSX Comparison

Compare GASS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GASS

StealthGas Inc.

N/A

Current Price

$7.39

Market Cap

297.3M

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$7.57

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GASS
BDSX
Founded
2004
2005
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.3M
276.2M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
GASS
BDSX
Price
$7.39
$7.57
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $32.17
AVG Volume (30 Days)
140.9K
★ 270.6K
Earning Date
12-01-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $88,499,000.00
Revenue This Year
N/A
$18.90
Revenue Next Year
N/A
$20.34
P/E Ratio
$5.00
★ N/A
Revenue Growth
N/A
★ 24.08
52 Week Low
$6.66
$5.26
52 Week High
$10.55
$31.97

Technical Indicators

Market Signals
Indicator
GASS
BDSX
Relative Strength Index (RSI) 29.37 20.77
Support Level N/A N/A
Resistance Level $9.00 $16.66
Average True Range (ATR) 0.27 1.73
MACD -0.04 -0.45
Stochastic Oscillator 2.63 0.00

Price Performance

Historical Comparison
GASS
BDSX

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: